Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study on the effect of FSH treatment on sperm epigenetics in severe oligozoospermia
2015-002521-19Phase 3Active
- Sponsor
- Health Research Institute Hospital La Fe
- Start
- Aug 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of recombinant human follicle stimulating hormone in male infertility and oligospermia (2 arms), sponsored by Health Research Institute Hospital La Fe. Primary endpoint: Changes in methylation of sperm DNA. Started Aug 2015; status: active.
02
Drugs
recombinant human follicle stimulating hormone
03
Conditions
male infertilityoligospermia
Beyond the preview
Go deeper on 2015-002521-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002521-19.